Birdwatch Archive

Birdwatch Note Rating

2024-01-15 01:37:27 UTC - NOT_HELPFUL

Rated by Participant: 94388E3CC445DC1A5E86E1D3CEE7EC9D576072CD0AE4F6394E55DB3282F80151
Participant Details

Original Note:

False claim. Vivek Ramaswamy owns a 7% stake in Roivant Sciences. Roivants financial interests in lipid nanoparticle delivery systems are publicly available in legal filings. Patent litigation involving Genevant/Roivant and Moderna are pending. https://investor.roivant.com/static-files/a7b36392-1f44-4251-87cf-8dd572f3034e https://www.fiercepharma.com/pharma/pandemic-patent-fights-continue-arbutus-genevant-coming-after-pfizer-and-biontech-new-suit

All Note Details

Original Tweet

All Information

  • noteId - 1746676161839607928
  • participantId -
  • raterParticipantId - 94388E3CC445DC1A5E86E1D3CEE7EC9D576072CD0AE4F6394E55DB3282F80151
  • createdAtMillis - 1705282647260
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 174667616183960792894388E3CC445DC1A5E86E1D3CEE7EC9D576072CD0AE4F6394E55DB3282F80151